Literature DB >> 3264711

Extended blood collection period required to define distribution and elimination kinetics of propofol.

G A Campbell1, D J Morgan, K Kumar, D P Crankshaw.   

Abstract

The pharmacokinetics of propofol were investigated following bolus intravenous administration of 2-3 mg kg-1 of drug to eight surgical patients. Apparent elimination half-life, volume of distribution and systemic blood clearance of propofol correlated strongly with the sampling period, which ranged from 8 to 52 h, depending on the time taken for the propofol concentration to reach the detection limit of the assay. In the three patients in whom the sampling period exceeded 42 h, apparent elimination half-life (55.6 h) and apparent volume of distribution (1370 l) greatly exceeded previously published estimates and systemic blood clearance (1020 ml min-1) was much less than previous estimates. This suggests that previous estimates were biased by the relatively short duration of blood collection in those studies (8 to 12 h).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264711      PMCID: PMC1386527          DOI: 10.1111/j.1365-2125.1988.tb03386.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection.

Authors:  G F Plummer
Journal:  J Chromatogr       Date:  1987-10-09

3.  High-performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine.

Authors:  T B Vree; A M Baars; P M de Grood
Journal:  J Chromatogr       Date:  1987-07-03

4.  Blood disoprofol levels in anesthetised patients. Correlation of concentrations after single or repeated doses with hypnotic activity.

Authors:  H K Adam; B Kay; E J Douglas
Journal:  Anaesthesia       Date:  1982-05       Impact factor: 6.955

5.  The role of metabolism and protein binding in thiopental anesthesia.

Authors:  P G Burch; D R Stanski
Journal:  Anesthesiology       Date:  1983-02       Impact factor: 7.892

6.  Pharmacokinetics of propofol in female patients. Studies using single bolus injections.

Authors:  I D Cockshott; L P Briggs; E J Douglas; M White
Journal:  Br J Anaesth       Date:  1987-09       Impact factor: 9.166

7.  Disposition of propofol in patients undergoing surgery. A comparison in men and women.

Authors:  N H Kay; J W Sear; J Uppington; I D Cockshott; E J Douglas
Journal:  Br J Anaesth       Date:  1986-10       Impact factor: 9.166

  7 in total
  9 in total

1.  Pharmacokinetics of propofol when given by intravenous infusion.

Authors:  D J Morgan; G A Campbell; D P Crankshaw
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

2.  Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.

Authors:  C A Knibbe; H J Voortman; L P Aarts; P F Kuks; R Lange; H J Langemeijer; M Danhof
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 3.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

4.  First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial.

Authors:  Ann E Rigby-Jones; J Robert Sneyd; Peter Vijn; Patrick Boen; Maurice Cross
Journal:  BMC Anesthesiol       Date:  2010-06-29       Impact factor: 2.217

Review 5.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

6.  The use of PBPK modeling across the pediatric age range using propofol as a case.

Authors:  Robin Michelet; Jan Van Bocxlaer; Karel Allegaert; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-10-08       Impact factor: 2.745

7.  The Effects of Propofol and Sevoflurane on Postoperative Delirium in Older Patients: A Randomized Clinical Trial Study.

Authors:  Xinchun Mei; Hai-Lin Zheng; Cheng Li; Xin Ma; Hui Zheng; Edward Marcantonio; Zhongcong Xie; Yuan Shen
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

8.  Human physiologically based pharmacokinetic model for propofol.

Authors:  David G Levitt; Thomas W Schnider
Journal:  BMC Anesthesiol       Date:  2005-04-22       Impact factor: 2.217

9.  A case of propofol-induced delayed-onset refractory myoclonic seizures.

Authors:  Hyung Won Jeon; Ji Hye Kang; Hyun Sook Kim; Hee Young Jo; Sang-Ho Kim
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.